Health News Releases

  • Today April 23
June 08, 2021 16:40
Agendia’s MammaPrint® Test is the First to Demonstrate the Ability to Predict Benefit from Extended Endocrine Treatment in NSABP B-42 Trial
Agendia, Inc., a world leader in precision oncology for breast cancer, today announced positive results from an analysis using its 70-gene MammaPrint® assay on samples from the NSABP B-42 trial. These
June 08, 2021 16:30
Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat
June 08, 2021 11:45
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today at the American Transplant Congress (ATC) 2021 Virtual Connect presented results from a new subgroup analysis of SOT recipien
June 08, 2021 10:30
Iksuda Therapeutics Closes $47 Million Financing Round
Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced it has completed a US $47 million (circa GB £34 millio
June 07, 2021 11:50
Analysis of MINDACT Study Confirms MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk Breast Cancers
Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that data from the landmark MINDACT study will be shared at the 2021 American Society of Clinical Oncology (ASCO)
June 07, 2021 11:10
Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations
Agendia, Inc., a world leader in precision oncology for breast cancer, announced that new data from the first-of-its kind, national FLEX registry was debuted today at the 2021 American Society of Clin
June 07, 2021 10:50
ASCO 2021 Podium Presentation on Agendia FLEX Study Shows Clinical & Molecular Differences in Tumors of African American and Caucasian Patients with HR+ Breast Cancer, Underscores Importance of Genomic Insights to Understand Disparities in Outcomes
Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that an oral presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting revealed new da
June 04, 2021 17:35
Humanigen to Present at the 2021 LD Micro Invitational XI
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab,
June 04, 2021 14:00
Cardiac Insight Announces Expansion Into More Than 20 Asia-Pacific Markets with i.SigNal by Dreamtech Partnership
Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced today that it has entered into a distributi
June 04, 2021 13:30
Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels
Crown Bioscience (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of
June 04, 2021 11:00
Organon Launches as New Global Women’s Health Company
Organon (NYSE: OGN), today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at t
June 03, 2021 11:55
Boehringer Ingelheim and Zealand Pharma Receive FDA Fast Track Designation for Investigational Treatment for NASH
Boehringer Ingelheim and Zealand Pharma A/S (Nasdaq: ZEAL) (CVR-no. 20045078) today announced that the US Food and Drug Administration (FDA) has granted Fast Track Designation to the GLP-1/glucagon du
June 03, 2021 11:30
Benson Hill - Sustainable Food Technology Company Driving the Plant-Based Food Revolution - to Combine With Star Peak Corp II
Benson Hill, Inc. (the “Company” or “Benson Hill”), a food technology company unlocking the natural genetic diversity of plants, announced today that it will become publicly listed through a business
June 02, 2021 16:30
DentalMonitoring Continues to Disrupt the Orthodontic Market With AI-powered Solutions for Braces and Aligners of All Brands
The company that pioneered the field of virtual orthodontics and has been the market leader since 2014 is revolutionizing the industry once again with the only available AI-based virtual monitoring so
June 02, 2021 09:50
ZOLL and Global Healthcare SG Sign Exclusive Agreement for Distribution of Portable Targeted Temperature Management System in Asia Pacific
ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Global Healthcare SG, a developer of portable body cooling solutions, today anno
May 31, 2021 15:00
Waters Introduces the SARS-CoV-2 LC-MS Kit (RUO) to Advance Clinical Research of Infectious Diseases
Waters Corporation (NYSE:WAT) today introduced a new RUO LC-MS test method to advance critical infectious disease research. Waters™ SARS-CoV-2 LC-MS Kit (RUO) uses an orthogonal analytical method that
May 31, 2021 14:10
Humanigen Submits Application to FDA for Emergency Use Authorization for Lenzilumab in COVID-19
Humanigen, Inc. (Nasdaq:HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate
May 31, 2021 13:30
NEC’s AI Supports Doctors to Detect Neoplasia in Barrett’s Esophagus During Endoscopic Procedures
NEC Corporation (NEC; TOKYO: 6701) today announced the development of an AI technology for supporting doctors to detect neoplasia in Barrett’s esophagus during endoscopic procedures. This is the world
‘The NANUM Volunteer Corps’ of Siemens Korea are preparing daily necessities for around 230 househol
May 31, 2021 10:34
Siemens Korea Donates Daily Necessities for Needy Neighbors in the Local Community
A global powerhouse in electrical engineering and electronics Siemens Korea announced on May 31 that the company will carry out the ‘Delivery of Daily Necessities’ citizenship program with Seodaemun C
iTind is the newest addition to the portfolio of Olympus, a market leader in devices for BPH treatme
May 28, 2021 15:05
Olympus Acquires Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth
Olympus Corporation (”Olympus” - Director, Representative Executive Officer, President and CEO: Yasuo Takeuchi) announced today that it has finalized the acquisition of Israeli medical device company
May 27, 2021 15:30
GM-CSF Gene-Edited CAR-T Data to be Presented at International Society for Cell & Gene Therapy Annual Meeting 2021
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab™
May 27, 2021 11:10
BIO KOREA 2021 International Convention to Unlock the Secret of Future Technologies
As one of the most important global bio-health conventions, BIO KOREA 2021 International Convention has garnered great attention from home and abroad. To facilitate the discussion on the future bio-he
May 25, 2021 15:40
Illumina and Microba Life Sciences Partner to Accelerate Microbiome Research
Illumina, Inc., the global leader in DNA sequencing and array-based technologies, announced today it united with leaders in precision gut microbiome science Microba Life Sciences to advance understand
May 24, 2021 16:30
Ferring and Rebiotix Present Positive Interim Phase 3 Results From Open-Label Study of Investigational Microbiota-Based Live Biotherapeutic RBX2660 at Digestive Disease Week® (DDW)
Ferring Pharmaceuticals and Rebiotix, a Ferring Company, announced today the first presentation of interim data from a Phase 3 open-label study showing strong trends in efficacy and safety for investi
May 24, 2021 15:40
Potential Impact of Takeda’s Dengue Vaccine Candidate Reinforced by Long-Term Safety and Efficacy Results
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today announced that its dengue vaccine candidate (TAK-003) demonstrated continued protection against dengue illness and hospitaliz
25 per page50 per page75 per page100 per page